Narayan Bandekar Pharma And Energy Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-11-2024
- Paid Up Capital ₹ 0.60 M
as on 07-11-2024
- Company Age 16 Year, 11 Days
- Last Filing with ROC 31 Mar 2014
About Narayan Bandekar Pharma And Energy
- CIN/LLPIN
U24230GA2008PTC005972
- Company No.
005972
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2008
- Date of AGM
22 Jul 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
South Goa, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Narayan Bandekar Pharma And Energy?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Bandekar  | Director | 12-Dec-2008 | Current |
| Manda Bandekar | Director | 12-Dec-2008 | Current |
| Narayan Bandekar | Director | 12-Dec-2008 | Current |
| Rajan Bandekar | Director | 12-Dec-2008 | Current |
Financial Performance of Narayan Bandekar Pharma And Energy.
Enhance accessibility to Narayan Bandekar Pharma And Energy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Narayan Bandekar Pharma And Energy?
Unlock access to Narayan Bandekar Pharma And Energy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Narayan Bandekar Pharma And Energy LlpActive 10 years 21 daysAmit Bandekar, Narayan Bandekar and 1 more are mutual person
- Rajaram N S Bandekar And Company Private LimitedActive 51 years 3 months
Amit Bandekar, Narayan Bandekar and 1 more are mutual person
- Rajaram Bandekar (Sirigao) Mines Private LimitedActive 52 years 4 months
Amit Bandekar, Narayan Bandekar and 1 more are mutual person
- Bandekar Minerals Private LimitedActive 49 years 6 months
Amit Bandekar and Narayan Bandekar are mutual person
- Rupa Minerals Private LimitedActive 49 years 6 months
Amit Bandekar and Narayan Bandekar are mutual person
- Narayan Bandekar And Sons Private LimitedActive 38 years 10 months
Amit Bandekar, Narayan Bandekar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Narayan Bandekar Pharma And Energy?
Unlock and access historical data on people associated with Narayan Bandekar Pharma And Energy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Narayan Bandekar Pharma And Energy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narayan Bandekar Pharma And Energy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
